Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout.
Hansildaar R, Vedder D, Baniaamam M, Tausche AK, Gerritsen M, Nurmohamed MT. Hansildaar R, et al. Among authors: gerritsen m. Lancet Rheumatol. 2021 Jan;3(1):e58-e70. doi: 10.1016/S2665-9913(20)30221-6. Epub 2020 Sep 1. Lancet Rheumatol. 2021. PMID: 32904897 Free PMC article. Review.
Effects of intensive urate lowering therapy with febuxostat in comparison with allopurinol on pulse wave velocity in patients with gout and increased cardiovascular risk: the FORWARD study.
Desideri G, Rajzer M, Gerritsen M, Nurmohamed MT, Giannattasio C, Tausche AK, Borghi C. Desideri G, et al. Among authors: gerritsen m. Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):236-242. doi: 10.1093/ehjcvp/pvaa144. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 33410912 Clinical Trial.
Coagulation in gout: is there a link with disease activity?
Vedder D, Gerritsen M, Meijers JCM, Nurmohamed MT. Vedder D, et al. Among authors: gerritsen m. Clin Rheumatol. 2022 Jun;41(6):1809-1815. doi: 10.1007/s10067-022-06047-9. Epub 2022 Feb 1. Clin Rheumatol. 2022. PMID: 35102534 Free PMC article.
COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases.
Boekel L, Hooijberg F, Besten YR, Vogelzang EH, Steenhuis M, Leeuw M, Atiqi S, van Vollenhoven R, Lems WF, Bos WH, Wijbrandts CA, Gerritsen M, Krieckaert C, Voskuyl AE, van der Horst-Bruinsma IE, Tas SW, Boers M, Rispens T, Nurmohamed MT, Wolbink G. Boekel L, et al. Among authors: gerritsen m. Lancet Rheumatol. 2022 May;4(5):e310-e313. doi: 10.1016/S2665-9913(22)00009-1. Epub 2022 Feb 8. Lancet Rheumatol. 2022. PMID: 35156061 Free PMC article. No abstract available.
Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study.
Boekel L, Hooijberg F, Vogelzang EH, Besten YR, Leeuw M, Atiqi S, van Vollenhoven RF, Wijbrandts CA, Gerritsen M, Krieckaert C, Dijkshoorn B, Bakhlakh S, Crooijmans JJ, Voskuyl A, van der Horst-Bruinsma IE, Lems W, Kuijpers TW, van Ham SM, Wieske L, Eftimov F, Kummer LY, van Dam PK, Stalman EW, Steenhuis M, Keijzer S, Cristianawati O, Keijser J, Loeff FC, Tas SW, Nurmohamed MT, Boers M, Rispens T, Wolbink G. Boekel L, et al. Among authors: gerritsen m. RMD Open. 2022 Apr;8(1):e002035. doi: 10.1136/rmdopen-2021-002035. RMD Open. 2022. PMID: 35383121 Free PMC article.
338 results